Spacers modifications impart a number of desirable benefits:
- Reduce interaction by creating greater distance: : Spacers can be used in
conjunction with 3' and 5'-amino-modifiers and/or additional spacers to place tags
at greater distances from the oligonucleotide and reduces interaction between the
oligonucleotide and the fluorescent dye1.
- Reduce steric interaction: Spacer can increase hybridization to a support
bound oligonucleotide by reducing steric interaction between support and bound oligo2
.
- Base mimic: The C3 spacer can be used to mimic the three carbon spacing between
the 3'- and 5'-hydroxyls of the oligonucleotide3 or replace a base within
a sequence when the base is unknown.
- Abasic mimic: dSpacer modified oligonucleotide can be used to mimic abasic
sites within an oligonucleotide. It is known to undergo β-elimination reactions
and lead to single strand scission of DNA4,5
Type of Spacer Modifier
- Spacers C3, C6 and C12 spacers contain an aliphatic
linker which can be added to oligos requiring long spacer arms. In general, spacers
are used during oligonucleotide synthesis to introduce a longer arm into the sequence,
bridging sections of an oligonucleotide.
- C6, C16-6, C18-6 disulfide phosphoramidites contain
a disulfide linker which can be added to oligos requiring disulfide spacer arms.
- Polyethylene glycol PEG 9, 12, or atom 18 spacer, commonly known as HEG can be added
to oligos requiring hydrophilic spacer arms.
- Abasic and dSpacers are used to introduce a stable abasic site within an oligonucleotide.
- Hexadecane and octadecane phosphoramidites are hydrophobic.
Purification
Desalting or cartridge purification is acceptable for spacer modified oligonucleotide.
However, additional purification by HPLC is strongly recommended.
Quality Controls:
Every oligo synthesized is strictly controlled for quality by using either MALDI-TOF
mass spectrometry or polyacrylamide gel electrophoresis (PAGE) analysis. Final yields
are determined using UV absorbance at OD260 In addition, we perform QC
methods tailored to specific modifications, such as OD ratio measurement where appropriate.
Reference:
1. Trawick, B. N.; Osiek, T. A.; Bashkin, J. K. (2001) Bioconjugate Chem. 12, 900.
2. Takeshita, M.; Chang, C. N.; Johnson, F.; Will, S.; Grollman, A.P. (1987) J.
Biol. Chem. 262, 10171.
3. Kalnik, M.W.; Chang, C.N.; Grollman, A. P.; Patel, D.J. (1988), Biochemistry
27, 924
4. Sproat, B. S.; Beijer, B. S.; Rider, P.; Neuner, P. (1987) Nucleic Acids Research,
15, 4837.
5. Hermanson, G. T. Bioconjugate Techniques, Acedemic Press, San Diego.
Purification
Desalting or cartridge purification is acceptable for spacer modified oligonucleotide. However, additional purification by HPLC is strongly recommended.
Quality Controls
Every oligo synthesized is strictly controlled for quality by using either MALDI-TOF mass spectrometry or polyacrylamide gel electrophoresis (PAGE) analysis. Final yields are determined using UV absorbance at OD260 In addition, we perform QC methods tailored to specific modifications, such as OD ratio measurement where appropriate.
Cleavage Protocol
Optimal cleavage is obtained with exposure to long-wave UV light in the 300-350 nm spectral range. Cleavage releases the oligo with a 5'-phosphate group.